Are you Dr. Singer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-645-8800Fax+1 214-645-8801
Summary
- Dr. Mike Singer, MD is a board certified neurologist in Dallas, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with University of Texas Southwestern Medical Center and Parkland Health.
Education & Training
University of ChicagoResidency, Neurology, 2001 - 2004- University of ChicagoInternship, Internal Medicine, 2000 - 2001
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2000
Certifications & Licensure
TX State Medical License 2005 - 2026- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab Start of enrollment: 2011 Jul 01
Publications & Presentations
PubMed
- 9 citationsPeripheral neuropathy due to dinitrophenol used for weight loss: something old, something newLauren Phillips, Mike A. Singer
Neurology. 2013-02-19 - 4 citationsAn unusual case of Miller Fisher syndrome presenting with proptosis and chemosis.Maggie W. Waung, Mike A. Singer
Muscle & Nerve. 2012-05-01 - 37 citationsIdiopathic neuropathy: new paradigms, new promiseMike A. Singer, Steven Vernino, Gil I. Wolfe
Journal of the Peripheral Nervous System. 2012-05-01
Press Mentions
FDA Advisers Narrowly Endorse First Gene Therapy for Muscular DystrophyMay 12th, 2023- FDA Advisers Narrowly Back First Gene Therapy for Muscular DystrophyMay 12th, 2023
